InvestorsHub Logo
Followers 116
Posts 19015
Boards Moderated 0
Alias Born 08/27/2005

Re: None

Saturday, 03/26/2016 1:59:47 AM

Saturday, March 26, 2016 1:59:47 AM

Post# of 401949
So if ELI-216 has a market of ~$800 million and ELI-200 a market of ~$400 million and both of these are very conservative estimates
it does not take a rocket scientist to see why some in the pain management sector are beginning to become concerned.

Further it becomes a concern for these companies when they do not have any solutions themselves but for a few niche products.

Elite will be taking a bite out of revenues these companies now enjoy. Also the FDA will be requiring ADF solutions at some point in the not so distant future. These companies may need to get their opioids ADF licensed through Elite if they plan on maintaining some semblance of market share when all opioids are required to have an ADF attached. Fun times ahead.... for Elite.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News